Central diabetes insipidus in pediatric patients with Langerhans cell histiocytosis: Results from the JLSG-96/02 studies.
Kenichi SakamotoAkira MorimotoYoko ShiodaToshihiko ImamuraShinsaku Imashukunull nullPublished in: Pediatric blood & cancer (2018)
In the JLSG-96/02 studies, CDI developed in 15.8% of the cohort in which half as pre- and the other half as post-CDI. Relapse, particularly at the CNS risk sites, was linked with the development of post-CDI.